Skip to main content
logo
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
2.070
-0.070 (-3.27%)
At close: Aug 21, 2026, 4:00 PM EDT
2.066
-0.004 (-0.20%)
After-hours: Aug 21, 2026, 5:53 PM EDT

Polaryx Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-6.85-8.99-30.36-3.78
Stock-Based Compensation
0.634.732.43.24
Other Operating Activities
--26-
Change in Accounts Payable
0.530.4-0.4-0.05
Change in Other Net Operating Assets
-0.12-0.08-0.220.42
Operating Cash Flow
-5.81-3.94-2.57-0.17
Operating Cash Flow Growth
----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Short-Term Debt Issued
--0.070.13
Total Debt Issued
--0.070.13
Short-Term Debt Repaid
---0.19-
Total Debt Repaid
---0.19-
Net Debt Issued (Repaid)
---0.130.13
Issuance of Common Stock
14.074.497.32-
Other Financing Activities
-0.03-0.03--
Financing Cash Flow
14.054.477.190.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
8.240.524.62-0.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Levered Free Cash Flow
-2.090.510.99-
Unlevered Free Cash Flow
-2.090.510.99-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Change in Working Capital
0.410.32-0.620.37
SEC Filings: 10-K · 10-Q